Your browser doesn't support javascript.
loading
Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Ettinger, David S; Wood, Douglas E; Stevenson, James; Aisner, Dara L; Akerley, Wallace; Bauman, Jessica R; Bharat, Ankit; Bruno, Debora S; Chang, Joe Y; Chirieac, Lucian R; DeCamp, Malcolm; Dilling, Thomas J; Dowell, Jonathan; Durm, Gregory A; Gettinger, Scott; Grotz, Travis E; Gubens, Matthew A; Hegde, Aparna; Lackner, Rudy P; Lanuti, Michael; Lin, Jules; Loo, Billy W; Lovly, Christine M; Maldonado, Fabien; Massarelli, Erminia; Morgensztern, Daniel; Mullikin, Trey C; Ng, Thomas; Otterson, Gregory A; Patel, Sandip P; Patil, Tejas; Polanco, Patricio M; Riely, Gregory J; Riess, Jonathan; Shapiro, Theresa A; Singh, Aditi P; Tam, Alda; Tanvetyanon, Tawee; Yanagawa, Jane; Yang, Stephen C; Yau, Edwin; Gregory, Kristina M; Hughes, Miranda.
Afiliação
  • Ettinger DS; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Wood DE; Fred Hutchinson Cancer Center.
  • Stevenson J; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Centerand Cleveland Clinic Taussig Cancer Institute.
  • Aisner DL; University of Colorado Cancer Center.
  • Akerley W; Huntsman Cancer Institute at the University of Utah.
  • Bauman JR; Fox Chase Cancer Center.
  • Bharat A; Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • Bruno DS; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Centerand Cleveland Clinic Taussig Cancer Institute.
  • Chang JY; The University of Texas MD Anderson Cancer Center.
  • Chirieac LR; Dana-Farber/Brigham and Women's Cancer Center.
  • DeCamp M; University of Wisconsin Carbone Cancer Center.
  • Dilling TJ; Moffitt Cancer Center.
  • Dowell J; UT Southwestern Simmons Comprehensive Cancer Center.
  • Durm GA; Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
  • Gettinger S; Yale Cancer Center/Smilow Cancer Hospital.
  • Grotz TE; Mayo Clinic Cancer Center.
  • Gubens MA; UCSF Helen Diller Family Comprehensive Cancer Center.
  • Hegde A; O'Neal Comprehensive Cancer Center at UAB.
  • Lackner RP; Fred & Pamela Buffett Cancer Center.
  • Lanuti M; Mass General Cancer Center.
  • Lin J; University of Michigan Rogel Cancer Center.
  • Loo BW; Stanford Cancer Institute.
  • Lovly CM; Vanderbilt-Ingram Cancer Center.
  • Maldonado F; Vanderbilt-Ingram Cancer Center.
  • Massarelli E; City of Hope National Medical Center.
  • Morgensztern D; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
  • Mullikin TC; Duke Cancer Institute.
  • Ng T; The University of Tennessee Health Science Center.
  • Otterson GA; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
  • Patel SP; UC San Diego Moores Cancer Center.
  • Patil T; University of Colorado Cancer Center.
  • Polanco PM; UT Southwestern Simmons Comprehensive Cancer Center.
  • Riely GJ; Memorial Sloan Kettering Cancer Center.
  • Riess J; UC Davis Comprehensive Cancer Center.
  • Shapiro TA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Singh AP; Abramson Cancer Center at the University of Pennsylvania.
  • Tam A; The University of Texas MD Anderson Cancer Center.
  • Tanvetyanon T; Moffitt Cancer Center.
  • Yanagawa J; UCLA Jonsson Comprehensive Cancer Center.
  • Yang SC; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Yau E; Roswell Park Comprehensive Cancer Center.
  • Gregory KM; National Comprehensive Cancer Network.
  • Hughes M; National Comprehensive Cancer Network.
J Natl Compr Canc Netw ; 21(9): 961-979, 2023 09.
Article em En | MEDLINE | ID: mdl-37673108
ABSTRACT
Mesothelioma is a rare cancer originating in mesothelial surfaces of the peritoneum, pleura, and other sites. These NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) focus on peritoneal mesothelioma (PeM). The NCCN Guidelines for PeM provide recommendations for workup, diagnosis, and treatment of primary as well as previously treated PeM. The diagnosis of PeM may be delayed because PeM mimics other diseases and conditions and because the disease is so rare. The pathology section was recently updated to include new information about markers used to identify mesothelioma, which is difficult to diagnose. The term "malignant" is no longer used to classify mesotheliomas, because all mesotheliomas are now defined as malignant.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mesotelioma Maligno / Mesotelioma Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mesotelioma Maligno / Mesotelioma Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article